Blood Krebs von den Lungen-6 levels predict treatment response to antifibrotic therapy in patients with idiopathic pulmonary fibrosis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1465-993X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Blood Krebs von den Lungen-6 levels predict treatment response to antifibrotic therapy in patients with idiopathic pulmonary fibrosis ; volume:23 ; number:1 ; day:9 ; month:12 ; year:2022 ; pages:1-9 ; date:12.2022
Respiratory research ; 23, Heft 1 (9.12.2022), 1-9, 12.2022
- Creator
-
Choi, Myeong Geun
Choi, Sun Mi
Lee, Jae Ha
Kim, Joong-Yub
Song, Jin Woo
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12931-022-02273-6
- URN
-
urn:nbn:de:101:1-2023021909081328069786
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:58 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Choi, Myeong Geun
- Choi, Sun Mi
- Lee, Jae Ha
- Kim, Joong-Yub
- Song, Jin Woo
- SpringerLink (Online service)
Other Objects (12)
Antifibrotic therapy for idiopathic pulmonary fibrosis: time to treat
Efficacy of early antifibrotic treatment for idiopathic pulmonary fibrosis
Outcomes for hospitalized patients with idiopathic pulmonary fibrosis treated with antifibrotic medications
Antifibrotic therapies to control cardiac fibrosis
Self-reported Gastrointestinal Side Effects of Antifibrotic Drugs in Dutch Idiopathic Pulmonary Fibrosis patients
Prognostic role of MUC5B rs35705950 genotype in patients with idiopathic pulmonary fibrosis (IPF) on antifibrotic treatment
Computed tomography patterns predict clinical course of idiopathic pulmonary fibrosis
Inositol possesses antifibrotic activity and mitigates pulmonary fibrosis
Antifibrotic treatment response and prognostic predictors in patients with idiopathic pulmonary fibrosis and exposed to occupational dust
A model of human lung fibrogenesis for the assessment of anti-fibrotic strategies in idiopathic pulmonary fibrosis
Idiopathic pulmonary fibrosis
Idiopathic Pulmonary Fibrosis
Antifibrotic therapy for idiopathic pulmonary fibrosis: time to treat
Efficacy of early antifibrotic treatment for idiopathic pulmonary fibrosis
Outcomes for hospitalized patients with idiopathic pulmonary fibrosis treated with antifibrotic medications
Antifibrotic therapies to control cardiac fibrosis
Self-reported Gastrointestinal Side Effects of Antifibrotic Drugs in Dutch Idiopathic Pulmonary Fibrosis patients
Prognostic role of MUC5B rs35705950 genotype in patients with idiopathic pulmonary fibrosis (IPF) on antifibrotic treatment
Computed tomography patterns predict clinical course of idiopathic pulmonary fibrosis
Inositol possesses antifibrotic activity and mitigates pulmonary fibrosis
Antifibrotic treatment response and prognostic predictors in patients with idiopathic pulmonary fibrosis and exposed to occupational dust
A model of human lung fibrogenesis for the assessment of anti-fibrotic strategies in idiopathic pulmonary fibrosis
Idiopathic pulmonary fibrosis
Idiopathic Pulmonary Fibrosis
Antifibrotic therapy for idiopathic pulmonary fibrosis: time to treat
Efficacy of early antifibrotic treatment for idiopathic pulmonary fibrosis
Outcomes for hospitalized patients with idiopathic pulmonary fibrosis treated with antifibrotic medications
Antifibrotic therapies to control cardiac fibrosis
Self-reported Gastrointestinal Side Effects of Antifibrotic Drugs in Dutch Idiopathic Pulmonary Fibrosis patients
Prognostic role of MUC5B rs35705950 genotype in patients with idiopathic pulmonary fibrosis (IPF) on antifibrotic treatment
Computed tomography patterns predict clinical course of idiopathic pulmonary fibrosis
Inositol possesses antifibrotic activity and mitigates pulmonary fibrosis
Antifibrotic treatment response and prognostic predictors in patients with idiopathic pulmonary fibrosis and exposed to occupational dust
A model of human lung fibrogenesis for the assessment of anti-fibrotic strategies in idiopathic pulmonary fibrosis
Idiopathic pulmonary fibrosis